Polaris Pharmaceuticals 2025 Q4 Financial Report
Polaris Pharmaceuticals, Inc. (stock code: 6550) reported a basic EPS of -5.10 NTD, revenue of 0.41 … · 2025-12-01
北極星藥業集團股份有限公司 News Releases
[Polaris Group] 2026 Q1 EPS -0.64 NTD
Polaris Group reported Q1 2026 EPS of -0.64 NTD and a net loss of 554 million NTD. · 2026-03-01
Polaris Pharmaceuticals 2025 Q4 Financial Report
Polaris Pharmaceuticals, Inc. (stock code: 6550) reported a basic EPS of -5.10 NTD, revenue of 0.41 … · 2025-12-01
[Polaris Group] 2026 Q1 EPS -0.64 NTD
Polaris Group reported Q1 2026 EPS of -0.64 NTD and a net loss of 554 million NTD. · 2026-03-01